Literature DB >> 15067176

Ghrelin expression in hyperplastic and neoplastic proliferations of the enterochromaffin-like (ECL) cells.

Amitabh Srivastava1, Anitha Kamath, Shepard-Annette Barry, Yogeshwar Dayal.   

Abstract

Ghrelin, a recently discovered peptide isolated from the gastric corpus mucosa, is believed to be important in the regulation of growth hormone secretion and has been shown to increase appetite and food intake as well. It may also have other gastrointestinal and cardiac functions. Because a cell of origin for ghrelin has not been convincingly identified in the gastric mucosa thus far, we studied the immunohistochemical expression of ghrelin in proliferative lesions of the enterochromaffin-like (ECL) cells-a cell that is not only exclusively confined to the gastric corpus mucosa but is its dominant endocrine cell type as well. Formalin-fixed, paraffin embedded tissues from three cases of gastric ECL cell hyperplasia and five ECL carcinoids (three with coexisting foci of diffuse, linear, and micronodular hyperplasia) were immunohistochemically stained for ghrelin, using a commercially available antibody. The Sevier-Munger stain for ECL cells and immunohistochemical stains for chromogranin, gastrin, serotonin, somatostatin, and vesicular monoamine transporter-2 (VMAT-2) were performed on parallel sections for correlation with the ghrelin staining results. All ECL cell carcinoids and hyperplastic lesions were positive for both the Sevier-Munger and the immunohistochemical stains for chromogranin and VMAT-2. Immunoreactivity for ghrelin was seen in 4/5 ECL carcinoids, all cases of ECL cell hyperplasia, as well as in all areas with linear and micronodular hyperplasia adjacent to the ECL cell carcinoids. In each instance, such staining was confined to the Sevier-Munger, and VMAT-2 positive cells only. Our findings indicate that the ECL cells are either the ghrelin-producing cells of the gastric mucosa or acquire the capability to synthesize ghrelin during proliferative states encompassing the entire hyperplasia to neoplasia spectrum. In view of the orexigenic and other known actions of ghrelin, the functional and/or biologic significance of ghrelin production in such ECL cell proliferations needs to be investigated further.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15067176     DOI: 10.1385/ep:15:1:47

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  31 in total

Review 1.  Gastric endocrine cells: types, function and growth.

Authors:  E Solcia; G Rindi; R Buffa; R Fiocca; C Capella
Journal:  Regul Pept       Date:  2000-09-25

2.  Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion.

Authors:  Yukari Date; Masamitsu Nakazato; Suzuko Hashiguchi; Katsuya Dezaki; Muhtashan S Mondal; Hiroshi Hosoda; Masayasu Kojima; Kenji Kangawa; Terukatsu Arima; Hisayuki Matsuo; Toshihiko Yada; Shigeru Matsukura
Journal:  Diabetes       Date:  2002-01       Impact factor: 9.461

3.  The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors.

Authors:  M Korbonits; S A Bustin; M Kojima; S Jordan; E F Adams; D G Lowe; K Kangawa; A B Grossman
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

4.  A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans.

Authors:  D E Cummings; J Q Purnell; R S Frayo; K Schmidova; B E Wisse; D S Weigle
Journal:  Diabetes       Date:  2001-08       Impact factor: 9.461

5.  Plasma ghrelin concentration and energy balance: overfeeding and negative energy balance studies in twins.

Authors:  E Ravussin; M Tschöp; S Morales; C Bouchard; M L Heiman
Journal:  J Clin Endocrinol Metab       Date:  2001-09       Impact factor: 5.958

6.  Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans.

Authors:  Y Date; M Kojima; H Hosoda; A Sawaguchi; M S Mondal; T Suganuma; S Matsukura; K Kangawa; M Nakazato
Journal:  Endocrinology       Date:  2000-11       Impact factor: 4.736

7.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

8.  Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans.

Authors:  F Broglio; E Arvat; A Benso; C Gottero; G Muccioli; M Papotti; A J van der Lely; R Deghenghi; E Ghigo
Journal:  J Clin Endocrinol Metab       Date:  2001-10       Impact factor: 5.958

9.  Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans.

Authors:  H Ariyasu; K Takaya; T Tagami; Y Ogawa; K Hosoda; T Akamizu; M Suda; T Koh; K Natsui; S Toyooka; G Shirakami; T Usui; A Shimatsu; K Doi; H Hosoda; M Kojima; K Kangawa; K Nakao
Journal:  J Clin Endocrinol Metab       Date:  2001-10       Impact factor: 5.958

10.  Characterisation of gastric ghrelin cells in man and other mammals: studies in adult and fetal tissues.

Authors:  Guido Rindi; Vittorio Necchi; Antonella Savio; Antonio Torsello; Michele Zoli; Vittorio Locatelli; Francesca Raimondo; Daniela Cocchi; Enrico Solcia
Journal:  Histochem Cell Biol       Date:  2002-05-29       Impact factor: 4.304

View more
  3 in total

1.  Ghrelin- and serotonin-producing gastric carcinoid.

Authors:  Eleanor Latta; Fabio Rotondo; Lawrence A Leiter; Eva Horvath; Kalman Kovacs
Journal:  J Gastrointest Cancer       Date:  2012-06

2.  Elevated serum ghrelin exerts an orexigenic effect that may maintain body mass index in patients with metastatic neuroendocrine tumors.

Authors:  Hank S Wang; David S Oh; Gordon V Ohning; Joseph R Pisegna
Journal:  J Mol Neurosci       Date:  2007-04-17       Impact factor: 3.444

3.  PACAP intraperitoneal treatment suppresses appetite and food intake via PAC1 receptor in mice by inhibiting ghrelin and increasing GLP-1 and leptin.

Authors:  John P Vu; Deepinder Goyal; Leon Luong; Suwan Oh; Ravneet Sandhu; Joshua Norris; William Parsons; Joseph R Pisegna; Patrizia M Germano
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-09-03       Impact factor: 4.052

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.